Back to mobile site

More on TVTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-96.6% Growth)
- Ratings (8.0 Score)

Upcoming Events

- Earnings (10/22/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Travere Therapeutics (NQ:TVTX)
Delayed: 66.26 +0.19 (0.29%)
Prev. Close $66.07  
Open$65.80 
52 Wk High$ 
52 Wk Low$ 
Day High$68.23 
Day Low$65.59 
P/E N/A  
EPS$ 
Volume747,867 

Friends, Peers and Foes (?): CSL, CSLLY, LGND, ARWR, CELC (more...)

Aug 19, 2026 04:05 PM Form 4 Travere Therapeutics, For: Aug 17 Filed by: LYONS GARY A
Aug 18, 2026 04:24 PM Form 144 Travere Therapeutics, Filed by: LYONS GARY A
Aug 17, 2026 04:32 PM Form 144 Travere Therapeutics, Filed by: LYONS GARY A
Aug 17, 2026 07:44 AM Travere Therapeutics (TVTX) PT Raised to $68 at Piper Sandler
Aug 14, 2026 10:29 AM Form SCHEDULE 13G/A Travere Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
Aug 12, 2026 05:00 PM Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 12, 2026 01:29 PM Form SCHEDULE 13G Travere Therapeutics, Filed by: BANK OF AMERICA CORP /DE/
Aug 7, 2026 11:03 AM Form SCHEDULE 13G Travere Therapeutics, Filed by: STATE STREET CORP
Aug 6, 2026 10:44 AM Form SCHEDULE 13G/A Travere Therapeutics, Filed by: FMR LLC
Aug 6, 2026 06:42 AM Travere Therapeutics (TVTX) PT Raised to $70 at Canaccord
View All Articles

Entities mentioned with TVTX

View All Entities